NCT07180381View on ClinicalTrials.gov

Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant Cancer

NARecruitingINTERVENTIONAL
Enrollment

503

Participants

Timeline

Start Date

May 14, 2025

Primary Completion Date

January 31, 2031

Study Completion Date

January 31, 2031

Conditions
Prostate Cancer
Interventions
OTHER

PSA and MRI-monitoring

Men with PI-RADS 3 or 4 lesions and a PSA density ≤ 0.15 ng/mL² are actively monitored with PSA testing every six months and MRI annually, instead of undergoing immediate prostate biopsy.

Trial Locations (6)

6842 CV

RECRUITING

Andros Clinics, Arnhem

6525 GA

RECRUITING

Radboud University Medical Centre, Nijmegen

Unknown

RECRUITING

Canisius Wilhelmina Hospital, Nijmegen

NOT_YET_RECRUITING

Antoni van Leeuwenhoek Hospital, Amsterdam

NOT_YET_RECRUITING

Maasstad Hospital, Rotterdam

3435 CM

RECRUITING

St Antonius Hospital, Nieuwegein

All Listed Sponsors
lead

St. Antonius Hospital

OTHER